Avistone Biotechnology
As of the edition of 20 October 2026, Avistone Biotechnology runs 5 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 5 |
| Total | 5 |
Where its trials are
- Cancer: 11 trials led
- Lungs and airways: 9 trials led